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Abstract
Thymidylate synthase (TS), which catalyzes the de novo synthesis of dUMP, is an important target for cancer therapy. In this
report, the effects of 5-fluorouracil (5-FU) and ZD1694 on the regulation of TS gene expression were evaluated in zebrafish
embryos. Our results revealed that the expression of TS was increased by about six-fold when embryos were treated with
1.0 mM 5-FU and there was a greater than 10-fold increase in the TS protein level after treatment with 0.4 mM ZD1694.
Northern blot analysis confirmed that expression of TS mRNA was identical in treated or untreated embryos. Gel shift and
immunoprecipitation assays revealed that zebrafish TS was specifically bound with its cognate mRNA in vitro and in vivo.
We identified a 20 nt RNA sequence, TS:N20, localized to the 59-UTR of TS mRNA, which corresponded to nt 13–32; TS:N20
bound to the TS protein with an affinity similar to that of the full-length TS mRNA. The MFold program predicted that
TS:N20 formed a stable stem-loop structure similar to that of the cis-acting element found in human TS mRNA. Variant RNAs
with either a deletion or mutation in the core motif of TS:N20 were unable to bind to the TS protein. In vitro translation
experiments, using the rabbit lysate system, confirmed that zebrafish TS mRNA translation was significantly repressed when
an excess amount of TS protein was included in the system. Additionally, a TS stability experiment confirmed that treatment
of zebrafish embryos with 5-FU could increase the TS stability significantly, and the half life of TS protein was about 2.7
times longer than in untreated embryos. Our study revealed a structural requirement for the interaction of TS RNA with TS
protein. These findings also demonstrated that the increase in TS protein induced by 5-FU occurs at the post-transcriptional
level and that increased stability and translation efficiency both contributed to the increase in TS protein levels induced by
TS inhibitors.
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Introduction
Thymidylate synthase (TS) is a folate-dependent enzyme that
catalyzes the reductive methylation of dUMP to dTMP using 5,
10-methylenetetrahydrofolate as a one-carbon donor. This
enzyme has been an important target for cancer chemotherapy
for several decades because TS represents the sole de novo source
of thymidylate (dTTP), which is essential for DNA replication and
repair [1,2]. A number of studies using cultured cell lines, tumor
models and clinical specimens have shown that TS inhibitors
induce about a 2- to 4-fold increase in TS levels [3,4]. Such an
induction has been viewed as a potential barrier to successful
therapeutic outcomes because the response to TS-directed
chemotherapy is dependent on the enzyme concentration [5]. As
a result, extensive studies have been performed to elucidate the
mechanisms of inhibitor-mediated induction of TS and to develop
strategies to ameliorate the unwanted effects. Our previous study
confirmed that TS, in addition to its role in enzymatic catalysis,
also functions as an RNA binding protein [6,7]. Specifically,
translation of human TS mRNA is negatively regulated by direct
binding of TS to two different cis-acting elements in its cognate
mRNA. The first element is a 30-nt sequence found within the 59-
untranslated region (59-UTR) that includes the translational start
site in a stable stem-loop structure [8]. The second binding site is a
70-nt sequence corresponding to the nucleotides 480–550 [9].
When 5-fluorouracil (5-FU) or other TS inhibitors bind to TS, the
complex cannot interact with its cognate mRNA, which results in
increased TS protein expression [10].
There is additional evidence demonstrating that the fluoropyr-
imidine-mediated increase in TS protein expression is also due to
enhanced stability; treatment of human colon cancer HCT-15
cells with 5-FU, or other TS inhibitors, resulted in enhanced TS
protein stability. The half-life of TS in 5-FU-treated cells was
increased to around 25 h, compared to about 7 h for untreated
cells [11]. Further study suggested that 5-FU may interact with the
inactive form of TS, increasing its stability by changing the
molecular ternary conformation [12]. However, all of the above
studies were performed in cancer or normal cell lines. Further
study is essential to elucidate the mechanism of 5-FU-induced
over-expression in animal models.
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sequence but also on secondary folding. Work on RNA motif
discovery is relevant to better understand the metabolism of RNA,
which essentially relies on the interaction of transcripts with
proteins [13]. A web server for RNA data analysis, which has
significant capabilities for predicting the secondary structure of
RNA, has been reported by Khaladkar et al [14]. However, much
work remains to be done to determine the molecular mechanisms
underlying the structural requirements for protein-RNA interac-
tion [15]. Our previous studies demonstrated that an intact stem-
loop structure in the cis-acting element, localized up-stream of
human TS mRNA, is essential for TS mRNA-protein interaction.
However, the two cis-acting elements in human TS mRNA do not
display any homology in their primary sequences required for
human TS protein binding [8]. Deletion or mutation of key
nucleotides in the cis-acting element of human TS mRNA results
in loss of TS protein binding activity [16]. Further study is needed
to address whether there is similarity in the secondary structure of
the cis-acting elements in TS mRNA among different species.
The zebrafish model system is excellent for genetic, embryo-
logical, developmental and cell biological studies [17]. The
externally developing embryos are transparent, allowing for
visualization of organ systems. Zebrafish embryos exhibit unique
characteristics including ease of maintenance and drug adminis-
tration, a short reproductive cycle and transparency that permit
visual assessment of developing cells and organs. In recent years,
the zebrafish embryo has become an important vertebrate model
for assessing drug effects [18]. A previous study in our laboratory
demonstrated that zebrafish TS is a dimer with a molecular weight
of 72 kDa. Sequence analysis indicated that there is high similarity
(76%) between zebrafish and human TS, with the same folate
binding site and 93% similarity to the dUMP binding site [19].
However, little is known regarding TS regulation in response to 5-
FU in zebrafish embryos. Additionally, in order to develop
zebrafish as a whole-animal model for screening novel TS
inhibitors, a systematic study is a prerequisite for the elucidation
of the TS regulatory mechanism in zebrafish.
In the present report, using both in vitro and in vivo model
systems, we have demonstrated that zebrafish TS protein binds to
its own cognate mRNA, and the translational efficiency is
significantly suppressed by an excessive amount of TS protein.
Gel shift experiments and competition analyses revealed that a 20-
nt sequence in the 59-UTR of TS RNA is a critical site for TS
RNA–protein interaction. Furthermore, Western blot analysis
confirmed that TS stability was also significantly increased in
response to treatment with 5-FU.
Results
It is well documented that TS inhibitors such as 5-FU and
ZD1694 can promote a 2–4-fold increase in the TS enzyme level
in cultured cell lines, tumor models and clinical specimens [3,4].
To determine if the treatment of zebrafish embryos with 5-FU or
ZD1694 would also result in the over-expression of TS, Western
immunoblot analysis was performed to evaluate the TS expression
levels in untreated and 5-FU- or ZD1694-treated embryos. As
shown in figure 1, both 5-FU and ZD1694 significantly increased
TS expression in zebrafish embryos. At a concentration of 0.1–
1.0 mM 5-FU, TS expression was increased in a dose-dependent
manner (Fig. 1A, lane 1–5). The highest induction of TS
expression, which was about a 6.5-fold increase over untreated
embryos, was found in those treated with 1.0 mM 5-FU (Fig. 1 A,
B). Increasing 5-FU concentration to 2 mM did not result in an
additional enhancement in TS expression (data not shown). In
embryos treated with ZD1694, TS expression was more potently
increased; treatment with 0.4 mM ZD1694 resulted in 10 times
more TS expression compared to untreated embryos (Fig. 1C, D).
Of note, the expression of b-actin, remained unchanged in both
untreated and treated embryos. Northern blot analyses were also
performed to determine changes in the TS mRNA level in
response to 5-FU and ZD1694 treatment. Treatment of zebrafish
embryos with 0.1, 0.2, 0.5 or 1.0 mM 5-FU for 24 h did not result
in any alteration of the TS mRNA level (Fig. 1A, panel 3).
Similarly, the mRNA level was also unaffected following treatment
with various concentrations of ZD1694 (Fig. 1C, panel 3). These
findings suggested that the induction of TS protein in zebrafish
after drug treatment is dose-dependent and occurs at the post-
transcriptional level.
To more precisely identify the underlying molecular events of
the regulation of TS gene expression, the level of TS protein was
determined in response to 5-FU drug treatment for varying
amounts of time. Densitometry analysis of the Western immuno-
blot experiments demonstrated a 3.0-, 4.1-, 6.2- and 7.4-fold
increase (Fig. 2B) in TS protein when zebrafish embryos were
treated with 1.0 mM 5-FU for 8 (Fig. 2A, lane 1), 16 (Fig. 2A, lane
2), 24 (Fig. 2A, lane 3) or 32 h (Fig. 2A, lane 4), respectively.
Furthermore, TS expression in untreated embryos remained
mostly unchanged from 8 to 32 h (Fig. 2A, lane 1–4). These results
suggest that 5-FU induced the expression of TS in zebrafish in a
time-dependent manner.
To determine if TS could bind to its cognate mRNA in vitro, we
performed an electrophoretic mobility shift assay (EMSA) with TS
recombinant protein and
32P-labeled full-length TS mRNA. A TS
mRNA probe was incubated with TS protein and analyzed using a
non-denaturing 5% acrylamide gel. The results demonstrated the
presence of a specific RNA-TS complex (Fig. 3, lane 1). To
determine the specificity of the TS–mRNA interaction, a 100-fold
excess of luciferase mRNA was included in the reaction mixture,
and the results demonstrated that luciferase mRNA did not affect
the binding of TS protein to its own mRNA (Fig. 3, lane 2). In
contrast, no interaction was found when an excess amount of TS
mRNA was added to the reaction mixture (Fig. 3, lane 3).
Replacing TS protein with BSA also did not lead to a bound
complex (Fig. 3, lane 4). These results demonstrated that the TS
protein could bind specifically to its cognate mRNA in vitro.
In order to more precisely localize the TS binding site in the
full-length TS mRNA, we initially performed a series of RNA
competition gel mobility-shift experiments. Several TS RNA
sequences from zebrafish TS mRNA were synthesized in vitro and
used as unlabeled RNA competitors in gel mobility-shift assays to
determine the relative binding affinity (IC50) of zebrafish TS
protein for each sequence (Table 1). Full-length TS mRNA
effectively competed for TS protein binding (Table 1,
IC50=0.50 nM), while the luciferase mRNA had a 1000-fold
lower protein binding affinity than the TS full-length mRNA
(Table 1). TS mRNA sequences, including TS 1–580, TS 1–290,
TS 1–145, TS 1–72 and TS 1–36 displayed similar TS protein
binding activity as the full-length TS mRNA in the competition
assay (Table 1). However, the TS mRNA sequences TS 581–1163,
TS 291–580, TS 146–290, TS 73–145 and TS 37–74 were unable
to compete for TS protein binding (Table 1). The results from
these competition experiments suggested the presence of a TS
binding site within the first 37 nt of the TS mRNA.
Previous studies have demonstrated that a stem-loop secondary
structure is present in the upstream region of human TS mRNA,
which included AUG site, that plays key roles in RNA and human
TS protein interaction [8,16]. In the present study, the first 37 nt
in the TS RNA sequence were subjected to MFOLD analysis
Regulation of TS
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dicted stable stem-loop structure was found in nt13–32 in TS
mRNA, designated TS:N20 (Fig. 4A). To more accurately define
the sequence and/or structural requirements for the RNA–protein
complex formation within this specific region, we synthesized the
20-nt RNA construct (nt 13–32) found in the 59UTR of the TS
RNA sequence. TS:N20 competed for TS protein binding with
activity similar to the full-length TS RNA (Table 1,
IC50=0.62 nM).
An RNA gel mobility shift assay was used to determine
structural requirements for the TS:N20–TS protein interaction.
32P-labled TS:N20 RNA could form an RNA–protein complex in
the presence of 100 ng pure recombinant TS protein (Fig. 5A, lane
2). In contrast, deleting of the UGC sequence in the loop structure
of theTS:N20, the mutant D20-TS resulted in complete loss of this
interaction (Fig. 5A, lane 3). To provide further support for the
importance for maitain an intact stem-loop structure, two other
TS RNA variants were synthesized: D20–18-TS RNA, which
contained a two base substitution, GURCA, at nt 18 and 19, and
D20–23-TS RNA, which contained base substitutions, GCUR
AAA, at nt 23–25. These two TS RNA variants were unable to
form a TS–RNA complex with the zebrafish TS protein (Fig. 5A,
lanes 4 and 5). Additionally, when 100 ng full-length TS mRNA
was included in the reaction mixture, the interaction of TS:N20
with TS protein was abolished completely (Fig. 5A, lane 6). To
more precisely measure the ability of these three RNAs to interact
with TS protein, we determined their relative binding affinity for
TS protein compared to full-length RNA. TS:N20 bound TS
protein with a relative affinity (Table 1, IC50=0.62 nM; Fig. 5B,
panel 1) similar to the full-length RNA. The three RNA variants,
D20-TS RNA, D20–18-TS RNA and D20–23-TS RNA, were
unable to compete with
32P-labeled full-length TS RNA for TS
protein binding, even at a high concentration (Fig. 5B, panel 2–4).
The MFold program was used to predict the stability of the
secondary structure of TS:N20 and its mutant constructs (Table 2).
Like TS:N20, both D20–18-TS and D20–23-TS RNA could form
a stable stem-loop structure. However, the loop of TS:N20
consisted of six nucleotides, while the loop in D20–18-TS and
D20–23-TS RNA contained only five and four nucleotides,
respectively. These findings suggested that TS:N20 localized to
the 59UTR of the TS RNA sequence is a critical site for TS
protein binding, and that some specific nucleotides and the loop
size of the secondary structure formed by the 20-nt sequence play
a key role in RNA–TS protein interaction.
To further assess the in vivo binding activity of TS protein,
zebrafish embryos were homogenized and the TS–mRNA
complex was immunoprecipitated using a TS monoclonal
antibody. Western blot analysis and RT-PCR experiments were
performed to determine if the precipitated complex included TS
mRNA and TS protein. The results demonstrated that TS protein
Figure 1. Expression profile of TS mRNA and protein in zebrafish embryos treated with 5-FU or ZD1694. Zebrafish embryos were
treated with various concentrations of 5-FU or ZD1694 for 24 h and the expression levels of TS mRNA and protein were evaluated. The TS mRNA and
protein level after 5-FU (A, B) or ZD1694 (C, D) treatment is shown. A, Zebrafish embryos were untreated (lane 1) or exposed to 0.1 mM (lane 2), 0.2 mM
(lane 3), 0.5 mM (lane 4) or 1.0 mM 5-FU (lane 5) for 24 h, and TS mRNA and protein expression was determined using Northern and Western blotting
analysis respectively. C, TS mRNA and protein level in untreated embryos (lane 1) or embryos treated with 0.1 mM (lane 2), 0.2 mM (lane 3), 0.3 mM
(lane 4) and 0.4 mM (lane 5) ZD1694, respectively. B and D, The quantification results of protein expression, which represent the protein expression
level after 5-FU or ZD1694 treatment, respectively, is shown. The TS expression level in untreated embryos was defined as 1.0.
doi:10.1371/journal.pone.0010618.g001
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antibody, TS106 (Fig. 6A, lane 2). TS mRNA from nt 340–1040
was also amplified by RT-PCR using TS-specific primers (Fig. 6B,
lane 4 and 5). In contrast, no specific interaction was detected
without the TS antibody (Fig. 6B, lane 2). Additionally, when an
unrelated monoclonal antibody was used, no amplified RNA was
detected (Fig. 6B, lane 3). These results confirmed that TS
interacted with its own RNA in vivo specifically.
To determine the biological relevance of the TS protein–
mRNA interaction, a rabbit reticulocyte lysate in vitro translation
system was used. Incubation of zebrafish TS mRNA with the
reticulocyte lysate yielded a protein product with a molecular mass
of approximately 35 kDa (Fig. 7A, lane 1). To determine if the
translation of TS was affected by the presence of other proteins,
BSA (Fig. 7A, lane 2), luciferase (Fig. 7A, lane 3), human p53
protein (Fig. 7A, lane 4) or alpha-chymotrypsin (Fig. 7A, lane 5)
were included in the translation mixture. Our results showed that
unrelated proteins did not affect TS translation (Fig. 7A, lane 1–5).
In contrast, when an excess amount of zebrafish TS protein was
added to the reaction mixture, the translation of TS mRNA was
significantly inhibited (Fig. 7B, lane 1–5). The formation of TS in
the translation system was negatively dose-dependent on the
amount of TS added to the translation system (Fig. 7B, lane 1–5).
Studies by Berger et al. revealed that treatment of cancer cells
with 5-FU resulted in increased stability of the TS protein [20]. In
order to determine if treatment with 5-FU affected TS stability in
zebrafish embryos, we examined the TS remained after the
Figure 2. Time-dependent effect of 5-FU on TS expression. Zebrafish embryos (n=100) were untreated or treated with varying
concentrations of 5-FU. A. Western immunoblot analyses were performed to evaluate TS levels in untreated zebrafish embryos or in embryos treated
with 1.0 mM 5-FU for 8 h (lane 1), 16 h (lane 2), 24 h (lane 3) and 32 h (lane 4). b-actin was used as internal control. B. The quantification results of
protein expression. The expression level of TS in untreated embryos at 8 h post-fertilization (hpf) was defined as 1.0. Each experiment was performed
more than three times.
doi:10.1371/journal.pone.0010618.g002
Figure 3. Specific interaction between zebrafish TS and its
cognate mRNA in vitro. A gel shift experiment was performed using
32P-labeled full-length TS mRNA as the probe. Zebrafish TS protein
(100 ng) was incubated with
32P-labeled full-length TS mRNA (lane 1,
arrow). One hundred-fold molar excess luciferase mRNA did not affect
the interaction between TS protein and mRNA (lane 2). In lane 3, 100-
fold molar excess of unlabeled TS mRNA was included in the incubation
buffer. Using bovine serum albumin in place of the TS protein did not
result in any specific interaction (lane 4). Lane 5 contained 100 ng
32P-
labeled zebrafish TS mRNA only.
doi:10.1371/journal.pone.0010618.g003
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times. As shown in Fig. 8B, 5-FU treatment of the embryos
significantly increased TS stability. Compared with the untreated
embryos, the half-life of TS increased by about 2.7 times; the
half-life of zebrafish TS increased from 7.2 h to around 19.5 h
after 5-FU treatment (Fig. 8A). These results suggested that
treatment of embryos with 5-FU could strongly enhance the
stability of TS.
Discussion
TS catalyzes the conversion of dUMP to dTMP and is therefore
indispensable for DNA replication in actively dividing cells. The
enzyme is a critical target for chemotherapeutic agents such as
fluoropyrimidines (e.g., 5-FU and 5-fluoro-29-deoxyuridine) and
folic acid analogues (e.g., raltitrexed, LY231514, ZD9331 and
BW1843U89) [1]. In this study, we demonstrated for the first time
that, after short-term exposure of zebrafish to 5-FU or ZD1694,
TS enzyme levels were elevated significantly. The enhancement of
TS expression induced by 5-FU is attributable to increased
translational efficiency as well as enhanced TS protein stability.
In our previous study, we found that human TS could bind to its
cognate mRNA and repress the translation of TS mRNA. Two
binding sites have been identified in human TS mRNA. One
binding site is located in the 59 region, encompassing a 30-nt
sequence that includes the translation start site, forming a stable
stem-loop structure [8]. The second binding site is a 70-nt
sequence in the protein-coding region that corresponds to
nucleotides 480–550 [16]. No similar sequences were found in
the corresponding regions of the zebrafish TS mRNA [19]. In the
present study, using gel mobility-shift analysis as well as
competition experiments, we have identified a cis-acting element
in the 59UTR of zebrafish TS mRNA. The RNA MFold program
predicted that this element, TS:N20, adopts a stable stem-loop
structure. Moreover, the three nucleotide sequence, UGC, which
is in the loop motif, and an intact stem-loop structure formed by
six-nucleotides are required for zebrafish TS protein–RNA
binding. Our previous studies demonstrated that a cis-acting
element that includes AUG localized upstream of human TS
mRNA, could form a stem-loop structure [6] that binds specifically
to human TS protein. Compared with the cis-acting element in the
upstream of human TS RNA (Fig. 4B), there is high similarity in
the secondary structure between the human and zebrafish cis-
acting elements. First, the core motif of both cis-elements is made
up of a stem consisting of a hexanucleotide and a loop structure
with six to seven nucleotides. Second, a non-Watson-Crick GU
base pairing is essential for maintaining the intact stem-loop
structure that allows for optimal interaction with the TS protein. A
precedent of the structural requirement study demonstrated that
maintaining an intact stem-loop structure is critical for protein
interaction with RNA. A stem-loop structure localized to the
39UTR of the b-subunit of the F0F1-ATPase mRNA is required
for the formation of an RNA–protein complex [21]. Iron
regulatory protein 1 (IRP1) binds iron-responsive elements (IREs)
in the 59UTR of mRNAs to repress translation or degradation.
Further studies revealed that the extended, L-shaped IRP1
molecule bound to the IRE stem-loop through interaction at
two sites separated by approximately 30 A ˚, each involving about a
dozen protein–RNA bonds [22]. Our present study provides
additional evidence that maintaining some precise secondary
structure of cis-acting elements is necessary for RNA–protein
complex formation. We are now trying to dissect the exact
interaction between the TS protein and the cis-element.
The redox state of TS plays a key role in the interaction
between human TS and mRNA. In the presence of reducing
agents, such as 2-mercaptoethanol and/or dithiothreitol, the RNA
binding activity of TS is significantly enhanced. In contrast,
treatment with oxidizing agents, such as diamide or N-ethylma-
leimide, significantly inhibits RNA binding activity [23]. Further
study in our laboratory confirmed that one of the amino acid
residues of human TS is crucial for TS–mRNA interaction and a
cysteine to alanine mutation at cysteine residue 180 completely
eliminated RNA binding activity. Mutations of other cysteines did
Table 1. Relative binding affinity of TS RNA constructs.
Constructs Sequences IC50,n M
Full-length TS
TS1–1163
0.5060.06
TS1–580 0.4860.08
TS1–290 0.4860.07
TS1–145 0.5260.08
TS1–72 0.6560.11
TS1–36 0.6060.14
TS:N20(TS13–32) 59-CUCUUGUUGUGCUGCAGGAU-39 0.6260.20
D20-TS RNA 59-CUCUUGUUGUGCAGGAU-39. 1000
D20-18-TS RNA 59-CUCUUCAUGUGCUGCAGGAU-39. 1000
D20-22-TS RNA 59-CUCUUGUUGUAAAGCAGGAU-39. 1000
TS581–1163 .1000
TS291–580 .1000
TS146–290 .1000
TS73–145 .1000
TS37–74 .1000
Luciferase RNA .1000
Binding of human TS protein to various RNA sequences was determined as
described in the Materials and Methods. The nucleotides in bold represent
point mutations. Each value represents the mean6SE of between three and five
experiments.
doi:10.1371/journal.pone.0010618.t001
Figure 4. Secondary structure of TS:N20. A, Secondary structure
for the zebrafish TS RNA sequence corresponding to nt 13–32, TS:N20,
which was predicted with the RNA MFold program, generating a stem-
loop secondary structure. B, The secondary structure of the cis-acting
element localized in the upstream region of human TS mRNA [8], which
binds specifically with human TS.
doi:10.1371/journal.pone.0010618.g004
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the zebrafish TS molecule [19]; we found that oxidizing agents like
diamide also inhibited the interaction between zebrafish TS and
mRNA (data not shown). We are currently examining which of the
cysteine residues are essential for RNA binding.
Previous studies have shown that human TS could also bind
with p53 and c-myc mRNA, repressing their translation in human
colon cancer cells [6,25]. Cancer cells that overexpress TS and
have suppressed levels of p53 are significantly impaired in their
ability to arrest in G1 phase in response to exposure to a DNA-
damaging agent such as gamma-irradiation [25]. Human TS
could bind with the C-terminal coding region of c-myc mRNA
and repressed its translation [26]. Considering the high similarity
between human and zebrafish TS, it is conceivable that zebrafish
TS may interact with c-myc and p53 in zebrafish embryos. Studies
are in progress in our laboratory to address if there are interaction
among TS and c-myc and/or p53 mRNA and if the interaction
affects the embronic development. Additionally, like in human
cancer cells, our initial studies confirmed that the metabolite of 5-
FU, FdUMP could also increase the expression of TS in zebrafish
embryos, and treatment of the embryos with FdUMP also
enhanced TS stability significantly. Treatment of embryos with
FdUMP (0.5 mM, Sigma, St. Louis, MO) increased TS level by
about 7-fold (data not shown), suggesting a similar mechanism in
this species as what is seen in humans.
Studies by other investigators have also found that the elevated
expression of TS after exposure to TS inhibitors was attributable
to increased protein stability [24]. The half-life of TS was
significantly increased in 5-FU-treated HCT-15 colon cancer cells
[11]. In the present study, we found that treatment of zebrafish
embryos with 5-FU increased the stability of TS protein
significantly and the half-life of TS in 5-FU-treated embryos was
increased to about 19.5 h compared to about 7.2 h seen in the
untreated embryos. Using a deletion approach to obtain a series of
mutants, Forsthoefel et al. [12] revealed that human TS molecules
lacking the N-terminal 12 or 29 amino acids were quite unstable in
transfected cells and had a half-life of only 1–2 h [27]. The N-
terminal sequence of the zebrafish TS is different from human TS.
Therefore, further study is needed to address whether the N-
terminal sequence of zebrafish TS also plays some role in TS
stability.
Western blot analysis confirmed that there was about a six-fold
increase in TS expression in 5-FU-treated embryos compared
with untreated embryos. Using a rabbit reticulocyte lysate
translation system, we found that excess exogenous TS could
inhibit TS mRNA translation significantly. Additionally, treat-
ment of embryos with 5-FU increased the TS stability
significantly. The results strongly support the idea that both
increased TS stability and enhanced TS translation efficiency
contributed to the 5-FU-induced augmentation of TS protein.
Taken together, our results provide evidence that both increased
TS stability as well as increased expression of TS account for the
enhancement of TS protein observed in response to fluoropyr-
imidine treatment. These findings also suggest that the auto-
regulatory mechanisms of TS may be a universal phenomenon
among different species from E. coli to zebrafish to human beings.
Additionally, our results provide evidence that some specific
nucleotides and an intact stem-loop structure are necessary for
the binding of TS protein to RNA. These findings enhance our
understanding of the structural requirements for the interaction
of RNA and protein.
Figure 5. Interaction of TS:N20 with zebrafish TS protein in vitro. A, Gel mobility shift analysis of TS:N20 interaction with TS protein. A 20-nt
TS RNA, which included nt 13–32, was synthesized and radio-labeled with
32P.
32P-labeled-TS:N20 RNA was incubated in the absence (lane 1) or
presence of 100 ng (lane 2) of pure recombinant zebrafish TS protein. A
32P-labeled 17-nt TS encompassing nt 13–32 with a deletion of the GCU
sequence, D20-TS RNA, was incubated in the presence of 100 ng of zebrafish TS protein (lane 3). Lanes 4 and 5 represent the other two mutation
variants, D20–18-TS RNA and D20–23-TS RNA, respectively, incubated with 100 ng of pure TS protein. TS:N25 RNA was incubated with 100 ng TS
protein in the presence of 100 ng unlabeled full-length TS mRNA (lane 6). Samples were resolved on a non-denaturing 5% acrylamide gel and
visualized by autoradiography. The specific RNA–protein complex is indicated (arrow). B, Competition analysis using TS oligomers with TS protein.
32P-labeled full-length TS RNA (10
5 cpm) was incubated with 200 ng of pure zebrafish recombinant TS protein in the presence of 0–10-fold molar
excess competitor, TS:N20 RNA (panel 1), D20-TS RNA (panel 2), D20–18-TS RNA (panel 3) and D20–23-TS RNA (panel 4). The RNA–protein complex
was resolved on a non-denaturing 5% acrylamide gel and visualized by autoradiography.
doi:10.1371/journal.pone.0010618.g005
Table 2. Stability of TS:N20 and its mutant constructs.
Constructs Sequences dG (kcal/mol)
TS:N20(TS13–32) 59-CUCUUGUUGUGCUGCAGGAU-392 5.3
D20-TS RNA 59-CUCUUGUUGUGCAGGAU-392 4
D20–18-TS RNA 59-CUCUUCAUGUGCUGCAGGAU-392 0.7
D20–23-TS RNA 59-CUCUUGUUGUAAAGCAGGAU-392 6.3
MFold Program was used to predict the stability of the secondary structure of
TS:N20 RNA and the mutant constructs. The nucleotides in bold represent point
mutations.
doi:10.1371/journal.pone.0010618.t002
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1. Maintenance of zebrafish embryos and drug treatment
Techniques for the caring and breeding of zebrafish have been
previously described [28]. Zebrafish embryos were reared in
0.0003% PTU to prevent pigmentation and staged at 28uC.
Collected embryos were maintained in an incubation buffer
(15 mM NaCl, 0.5 mM KCl, 1 mM CaCl2, 1 mM MgSO4,
0.15 mM KH2PO4, 0.05 mM Na2HPO4 and 0.7 mM NaHCO3)
at 28uC. The animal experiments were approved by the
Experimental Animal Center of Shandong province, China, and
the zebrafish embryos were treated in accordance with interna-
tional animal ethics guidelines.
Healthy embryos at the 1–2 cell stage were dechorionated by
enzymatic digestion using 1 mg/mL trypsin (Sigma, St. Louis,
Missouri) for 5–10 min at room temperature. The embryos were
then washed five times with the incubation buffer. Varying
concentrations of 5-FU or ZD 1694 were added directly to the
incubation buffer and maintained at standard condition for the
specified times.
2. Western blot
Western blot was performed as previously described to
determine the amount of TS in the developing embryos [19].
Briefly, equivalent amounts of crude protein (30 mg) from zebrafish
Figure 6. Zebrafish TS protein interacted with its own mRNA in vivo. A, Western blot analysis was performed with purified recombinant
zebrafish TS (lane 1) or protein from the immunoprecipitation complex (lane 2) and detected with human TS106 antibody. B, RT-PCR products using
the RNA extracted from immunoprecipitation complex as the template. TS mRNA from nt 340–1040 was amplified by RT-PCR using TS-specific
primers (lanes 4 and 5). RNA and protein complex was precipitated without TS antibody and RT-PCR was performed (lane 2). Lane 3 indicates the RT-
PCR results precipitating the complex with unrelated polyclonal antibody, CHX10-like zebrafish antibody (GenWay Biotech, CA). Lane 1 represents the
DNA marker of molecular weight.
doi:10.1371/journal.pone.0010618.g006
Figure 7. TS protein inhibited in vitro translation of zebrafish TS mRNA. A rabbit reticulocyte lysate in vitro translation system was used to
determine the interaction between mRNA and TS protein. Incubation of zebrafish TS mRNA with the reticulocyte lysate yielded a protein product
with a molecular mass of approximately 35 kDa. A, Zebrafish TS mRNA was incubated in the rabbit reticulocyte lysate system without (lane 1) or with
100 ng of BSA (lane 2), luciferase (lane 3), human p53 protein (lane 4) or alpha-chymotrypsin (lane 5). B, Excess TS protein was included in the reaction
mixture. Zebrafish TS mRNA was incubated in the translation system without (lane 1) or with 1 ng (lane 2), 10 ng (lane 3), 100 ng (lane 4) or 200 ng
(lane 5) TS protein.
doi:10.1371/journal.pone.0010618.g007
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were electro-blotted onto nitrocellulose membranes (Bio-Rad), and
filter membranes were then incubated in blocking solution
(16PBS, 0.2% Tween-20 and 5% non-fat dry milk powder) for
2 h at room temperature. Membranes were incubated overnight at
4uC with the anti-TS106 monoclonal antibody (A gift from Dr.
Carmen J. Allegra at the National Cancer Institute) at a dilution of
1:2000. After four 15-min washes in PBST (16PBS, 0.2% Tween-
20), membranes were incubated with horseradish peroxidase-
conjugated secondary antibodies at a dilution of 1:2000 (IgG goat
anti-mouse, Bio-Rad) for 1 h at room temperature. After an
additional four 15-min washes with PBST, membranes were
processed by the enhanced chemiluminescence method (Super-
Signal Substrate, Pierce) and protein bands were visualized using
autoradiography.
3. Isolation of RNA and Northern blot analysis
Zebrafish embryos were treated or untreated with 5-FU or
ZD1694 in the incubation buffer and the embryos were harvested
and homogenized after the specified incubation time. Total RNA
was extracted using the Qiagen total RNA extraction kit (Qiagen,
CA) following the manufacture’s protocol. For Northern blotting
analysis, 5 mg RNA was resolved on a 1% agarose/formaldehyde
gel and then transferred to a positively charged BrightStar-Plus
nylon membrane (Ambion, CA) by capillary transfer. Antisense
RNA probes were synthesized in vitro using the MEGAshortscript
T7 kit (Ambion, cat. no. 1354, CA). The TS antisense probe was
derived from a PCR-generated template complementary to
nucleotides 520–1216 of the zebrafish TS cDNA. RNA probes
were gel-purified and biotinylated using the BrightStar Psoralen-
Biotin non-isotopic labeling kit (Ambion, cat. no. 1480, CA). The
membrane was pre-hybridized for 2 h at 65uC followed by probe
hybridization overnight at 65uC. The BrightStar BioDetect kit
(Ambion, cat. no. 1930) was then used for detection of cellular
mRNAs. Quantification was performed using a Hewlett Packard
ScanJet 4P and NIH image 1.51 software.
4. RNA gel mobility shift assay
The recombinant zebrafish TS protein was expressed using
pET-28/Z-TS vector and the His-tag TS was purified using a
Ni-NTA spin kit (Qiagen, CA) as previously described [19].
After purification, the His-tagged TS protein was dissolved in
PBS buffer and thrombin (500 units) was added to incubate for
12 h at room temperature, and then dialyzed to PBS buffer to
remove His-tag. The solution of recombinant TS protein was
freeze-dried and stored at 220uC. RNA gel mobility shift
experiments were performed as described previously [16].
Briefly,
32P-labeled full-length TS RNA transcripts (TS1–
1163) were generated by in vitro transcription using the
MEGAshortscript T7 kit (Ambion, cat. no. 1354). A mixture
of the
32P-labeled TS RNA and 100 ng purified recombinant
protein was incubated at 37uC for 10 min and separated on a
non-denaturing polyacrylamide gel (5%, w/w, acrylamide/
N,N’-methylenebisacrylamide, 60:1). The resolved TS-RNA
complex was visualized by autoradiograghy.
Competition experiments were performed as previously de-
scribed [16] using 100 ng of recombinant zebrafish TS and 1 ng
of
32P-labeled full-length TS RNA (1610
5 c.p.m). These
conditions were selected based on experiments using a fixed
amount of radiolabled TS mRNA with increasing concentrations
of TS protein to determine the linearity of binding. Unlabeled TS
RNAs, including full-length TS mRNA TS1–1163, TS1–580,
TS1–290, TS1–145, TS1–72, TS1–36, TS13–32, TS581–1163,
TS291–580, TS146–290, TS73–145, TS37–72 and luciferase
mRNA at a concentration of 0–100-fold molar excess, were then
added to the reaction mixture prior to addition of TS protein. The
relative binding affinities (IC50) of TS RNA sequences for TS
protein were determined in terms of the concentration of
unlabeled RNA at which specific binding of
32P-labeled full-
length TS mRNA was inhibited by 50%. Quantification was
performed using a Hewlett Packard ScanJet 4P and NIH image
1.51 software. Each experiment was performed three to five
times.
Figure 8. Effect of 5-FU on the stability of TS protein in zebrafish embryos. Healthy embryos at the 1–2 cell stage were treated with 10 mg/
mL cycloheximide and 0.5 mg/mL 5-FU and incubated for another 4, 8, 16, 24 and 36 h. Embryos (n=100) that were untreated or treated with
cycloheximide and 5-FU were collected and the total protein was extracted for Western blot analysis as described in the Materials and Methods
section. A, TS level in the zebrafish embryo at various time points after 5-FU treatment. TS level in the absence (circles) or presence of 5-FU (box) was
analyzed by Western blot and quantified using a Hewlett Packard ScanJet 4P and NIH image 1.51 software. B, Western blot analysis showing the
amount of TS at specific times after treatment with cycloheximide. Zebrafish TS embryos were left untreated (panel 1) or treated with 5-FU (panel 2)
for 2 h, and 10 mg/mL cycloheximide was added to incubated for another 0 (lane 1), 4 (lane 2), 8 (lane 3), 16 (lane 4), 24 (lane 5) and 36 h (lane 6).
Western blots were performed as described in the Materials and Methods section.
doi:10.1371/journal.pone.0010618.g008
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Immunoprecipitation and RT-PCR analysis was carried out
according to our previously described methods with minor
modification [7]. Briefly, zebrafish embryos were cultured in the
incubation buffer for 24 h. Embryos were washed twice in ice-cold
phosphate-buffered saline and lysed with NET-2 lysis buffer. The
lysates were pre-cleared by incubating lysates with protein-A
agarose (Invitrogen, CA) for 3 h. Samples were then transferred to
new tubes for incubation with TS monoclonal antibody (1:2000)
for at least 3 h. All incubation steps were performed at 4uC.
Complexes were precipitated by centrifugation at 30006g and
washed with washing buffer I (50 mM Tris-HCl pH 7.5, 150 mM
NaCl, 1% NP-40, 0.5% sodium deoxycholate and 1 mM PMSF),
high salt washing buffer II (50 mM Tris-HCl pH 7.5, 500 mM
NaCl, 0.1% NP-40 and 0.05% sodium deoxycholate), low salt
washing buffer III (50 mM Tris-HCl pH 7.5, 0.1% NP-40 and
0.05% sodium deoxycholate) and TE buffer (10 mM Tris pH 8.0
and 1 mM EDTA). The presence of TS protein in the precipitated
complex was determined using Western blot analysis. RNA was
extracted from the complex using phenol-chloroform, and
precipitated by isopropyl alcohol for use as a template for cDNA
synthesize using random primers (TaKaRa Bio Group, Japan) and
M-MuLV reverse transcriptase (Promega, Madison, MI) accord-
ing to manufacturer’s protocol. The sequences of the primers used
for PCR were as follows:
TS340 (sense), 59-CGGAGAAAGCAAGAAAGAA-39
TS1040 (antisense), 59-GGGCGTCACCTAATGTATG-39
PCR reactions were carried out under standard conditions
(95uC for 1 min, 60uC for 1 min, 72uC for 90 s, for 30 cycles),
followed by a final extension step at 72uC for 5 min. PCR
products were resolved by electrophoresis using a 1.2% agarose gel
stained with ethidium bromide.
6. TS protein stability assay for zebrafish embryos
The half-life of TS was analyzed as described previously with
little modification [27]. Healthy embryos at the 1–2 cell stage were
dechorionated by enzymatic digestion with 1 mg/mL trypsin
(Sigma, St. Louis, Missouri) for 5–10 min at room temperature
and then cultured in six-well plates with 50 embryos per well.
Cycloheximide (10 mg/mL) was added to the incubation buffer.
After the embryos were cultured for 2 h, 0.5 mg/mL 5-FU was
added and embryos were incubated for another 4, 8, 16, 24 or
36 h. Dead and malformed embryos were removed. Untreated
embryos (n=100) and those treated with cycloheximide and 5-FU
were collected for analysis of the TS level using Western blot
analysis.
7. In vitro translation
Translation reactions were performed using a rabbit reticulo-
cyte lysate system (Promega, Madison, MI) per the manufacturer’s
instructions. Briefly, the translation reaction mixture (final volume,
20 mL) containing rabbit reticulocyte lysate, an amino acid
mixture without methionine (0.4 mL), ribonuclease inhibitor
(20 U) and
35S-methionine (12 mCi) were incubated with full-
length TS mRNA transcript at 30uC for 1 h. To examine the
influence of exogenous TS on the translation effect of TS, various
concentrations of TS were included in the translation system. The
translation product was analyzed using a 12% SDS-PAGE and
visualized using autoradiography after drying the gel for 1 h in a
gel dryer.
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